Group items tagged

eClinical solutions are used to improve the clinical development process through data analysis and management. It offers clinical and operational data by providing data management software and customized data management services, including clinical reporting, electronic data capture, data management and standardization, and clinical data repository platform, with total transparency. eClinical solutions allow users to standardize, integrate, manage, and analyze all their clinical and operational data with the help of integrated advanced visualization and analytical capabilities. Moreover, eClinical software help users to comply with budgeting, investigator management, patient management, government regulations, and adverse event reporting system among others. eClinical solutions integrate electronic health records, eTechnologies, electronic consent forms, clinical data management systems, and electronic data capture. Moreover, they are helping researchers in lengthy clinical research processes through proper management. eClinical solutions have gathered substantial market proposition among pharmaceutical and biopharmaceutical companies for streamlining their clinical trials and insights discovery across various phases from I to IV. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/01/eclinical-solutions-help-reduce-human.html

Pulmonary Arterial Hypertension (PAH) is a disease that affects the vasculature of the heart, specifically the arteries that transport blood from the heart to the lungs. Common symptoms include heart palpitations or an irregular rhythm, chest pain, coughing, wheezing, shortness of breath, chest discomfort when breathing, and sometimes even heart failure. The cause of pulmonary hypertension is not known, but research has indicated that genetic and hormonal factors may play a role in its development. The growing prevalence of Pulmonary Arterial Hypertension (PAH) is driving the growth of the Pulmonary Arterial Hypertension (PAH) Market. According to the European Respiratory Society, PAH is a rare disease, with an estimated prevalence ranging from 10 to 52 cases per million. The growing geriatric population is again increasing the prevalence of such disease which is also projected to foster the growth of the Pulmonary Arterial Hypertension (PAH) market. According to the United nation, by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). By 2050, one in four persons living in Europe and Northern America could be aged 65 or over. North America is projected to gain significant growth over the forecast period and this is attributed to the growing adoption of advanced treatment for treating pulmonary arterial hypertension. Moreover, increasing spending by the government on the healthcare sector is again augmenting the regional market growth. According to the U.S. Centers for Medicare & Medicaid Services, National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028. Reads more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/increasing-global-healthcare-spending.html

CMS' actions in response to COVID-19 as a direct liaison to the White House Task Force are worth knowing because that is how we know where the government stands.

CMS' actions in response to COVID-19 as a direct liaison to the White House Task Force are worth knowing because that is how we know where the government stands. As the pandemic-related deaths continue to occur in the New York State and other parts of the country,

The history of smartcards in healthcare dates back at least to the late 1990s. At that time, the French government began to offer each patient a small plastic card containing a microchip. Each patient then carries around his or her SmartCard. It serves as a virtual keypad on which to enter healthcare information. Smartcards and their associated software have been around since the time they were first introduced. However, as more healthcare companies became aware of the benefits they could see in implementing them into their business and the advantages they provided, they began to use them themselves. Today, nearly every hospital, doctor's office, pharmacy, nursing home, and other facility have some form of smart card or microprocessor smart card in use. A smart card is simply a magnetic strip that is used to make transactions from one place to another. Market Dynamics Increasing healthcare expenditure is expected to propel growth of the smart cards in healthcare market. For instance, according to The Centers for Medicare & Medicaid Services, the U.S. health spending is projected to reach nearly US$ 6.0 trillion by 2027. Moreover, emergence of Covid-19 has prompted several countries to develop vaccination proofing plans, which is also expected to aid in growth of the market. Digital credentials are expected to play a major role in management of the pandemic. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/emergence-of-covid-19-to-boost-adoption.html

Cancer is a disease caused when cells divide abnormally and uncontrollably and spread into surrounding tissues, which results in formation of a mass called tumor. Head and neck cancer refers to various malignant tumors that develop in or around the mouth, sinuses, nose, larynx, and throat. Moreover, head and neck cancer begin in squamous cells that line moist surfaces such as those inside the throat, nose, and mouth. Infection with human papillomavirus (HPV), excessive alcohol consumption, and chewing tobacco increases the risk of head and neck cancer. Other factors such as hereditary causes, Epstein barr virus infection, radiation exposure, occupational exposure, oral health, salted or preserved foods, excessive consumption of paan also increases the risk of head and neck cancer. Factors such as rise in government initiatives, surge in research and development activities, rise in health care infrastructure, and increase in the patient population are expected to propel the head and neck cancer market. Worldwide, head and neck cancer is the sixth-most common cancer, with around 630,000 people diagnosed every year, resulting in more than 350,000 deaths, according to the National Center for Biotechnology Information. Moreover, tens of millions of individuals are diagnosed with cancer each year and more than half of the patients eventually die from it. Moreover, cancer ranks the second most common cause of death in many countries, following cardiovascular diseases. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/head-and-neck-cancer-is-sixth-most.html

On Independence day 2020, The government of India has launched the National Digital Health Mission to digitize the health records of citizens/patients. With this digitization, the patient will now no longer be worried to take with him/her the health records while visiting the doctor for their health issues as everything would be available online, anytime and anywhere.

Increasing adoption of smartphones is expected to propel growth of the global online retail market. For instance, according to Pew Research Center, as of February 2019, 81% of U.S. adults used smartphones compared to 77% in October 2018. Moreover, increasing penetration of internet is also expected to aid in growth of the market. For instance, according to China government-backed Market Intelligence & Consulting Institute and reported by China Internet Watch, internet penetration in China reached 61.2 percent in the first half of 2019, with 854 million internet users at the end of June 2019. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global online retail market. For instance, in July 2020, Columbia Sportswear Company reported a 40% decline in overall net revenues in its July 2020 quarterly earnings report, due in part to pandemic-related store closures. However, the company's e-commerce sales increased 72% compared with the year-ago period. Moreover, increasing expenditure on personal care products is also expected to aid in growth of the market. For instance, according to the U.S. Bureau of Labor Statistics, average annual expenditure on personal care products in the U.S. increased from US$ 707 in 2016 to US$ 768 in 2018. Among regions, Asia Pacific is expected to witness significant growth in the online retail market. For instance, according to India Brand Equity Foundation, the e-commerce sector in India is expected to reach US$ 200 billion by 2026 from US$ 38.5 billion as of 2017. The market is also driven by significant growth in the FMCG sector. For instance, according to India Brand Equity Foundation, FMCG market in India is expected to grow at a CAGR of 27.86 per cent and is expected to reach US$ 103.70 billion by 2020 from US$ 52.75 billion in FY18. Read More @ https://coherentmarketinsights-blog.blogspot.com/2020/11/emergence-of-covid-19-to-augment-growth.html

Patient monitoring refers to the collection and analysis of medical data from one or more health settings (such as in hospitals or doctor's offices) for use by health care providers and other professionals in order to detect changes in an individual's medical status and to provide treatment options as needed. In health care, patient monitoring is generally the measurement of one or more medical parameters over extended periods of time, usually at different health care settings (such as in doctor's offices or hospitals). Patient monitoring may be implemented in many different health care settings including primary care offices, emergency rooms, doctors' offices, nursing homes, private practices, and government agencies. Most patient monitoring systems contain software that collect and store medical data in a database that is accessible to multiple health care providers and to health care facilities. High prevalence of chronic disorders is expected to propel growth of the global remote patient monitoring devices market over the forecast period. For instance, according to the study, "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition", published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045. Read More @ https://coherentmarketinsights-blog.blogspot.com/2020/11/high-prevalence-of-chronic-disorders-to.html

Biostimulants are natural or synthetic substances that aid in reducing the dependency on fertilizers. These substances are applied to seeds, plants, and soil in order to increase plant growth, resistance to water and abiotic stresses. Increasing global population has led to focus on boosting crop yield. According to projections by Population Reference Bureau (PRB) included in the 2018 World Population Data Sheet, the world population is expected to reach 9.9 billion by 2050, up 2.3 billion or 29% from an estimated 7.6 billion people in 2018. Moreover, according to according to Food and Agriculture Organization, worldwide food demand is expected to increase by 70% by 2050. Decrease in arable land in various regions has led to has led to various challenges in the agricultural sector. According to the study 'Will Limited Land, Water, and Energy Control Human Population Numbers in the Future', published in the journal Human Ecology, the amount of arable land available per person will decrease to 1500m² by 2050 from 4000m² in 1961. In July 2020, the government of India was expected to announce guidelines to regulate the biostimulants market in the country. Earlier, in July 2019, Europe witnessed several changes regarding definition and classification of these substances. Read More @ https://coherentmarketinsights-cmi.blogspot.com/2020/11/increasing-global-population-and-focus.html

The factors such as rise inpreference for minimally invasive surgeries and increase inprevalence of peripheral & coronary heart diseases are expectedto boost the growth of the atherectomy device market in thecoming years. Furthermore, favorable medical reimbursement scenario from the government is anticipated to propel theatherectomy devicemarket growth. However, lack of skilled professionals and stringent regulatory scenario is expected to restrain the market growth.

Overview: This seminar will provide an introduction to health care fraud and abuse and the laws and regulations that the government uses in its enforcement efforts. It will discuss the potential risks, the exposure of organizations, and the likelihood of increased enforcement efforts in the future.

Redsa is a technology provider focused on the health sector that facilitates the exchange of clinical and administrative information across its MediCloud network. This exchange is enabled by an interoperable platform in which all members of the sector interact and exchange information (insurers, hospitals, clinics, laboratories and government). Redsa has over 20 years of experience in the health sector and currently manages a network that integrates more than 40,000 health providers, 300 laboratories, 100 hospitals and 15 insurance companies.

In today's age, couples are facing a good number of issues when trying to conceive. The work environment, lifestyle and diet are quite essential factors governing the problem of infertility that many couples now-a-days are dealing with. In this article, we shall analyse the effects of weight, age and exercise on fertility.

Medical billing services are more of a conundrum in present times because the process has gotten complicated with time. The government has set value-based criteria for the providers to follow, for ensuring a productive health system while cutting costs.

Physical therapists are included as one of the groups of healthcare practitioners eligible for MIPS reporting in 2019. It was time their duties were rewarded with an open heart and a clear head. Physical therapy is a serious branch of medicine that, now, comes in the quality circle of the government where physical therapists (PTs) can receive incentives based on their performances.

However, with a much-improved situation now, the government encourages private practices and clinics to resume their normal operations. They are to continue with their postponed non-emergency treatments and carry out in-person patient visits as we speak.

America should adopt smarter ways to counter COVID-19 as it reopens for patients and clinicians. In the meanwhile, CMS has come up with a guide for patients and beneficiaries as they decide to visit providers for in-person care.

Due to the high unemployment rate and other drastic factors, the government suggests insurance companies to cover the COVID-19 tests for free. Read more in this article to know how healthcare organizations still have confusion regarding payment.

Myelofibrosis Treatment includes medications and surgery. There are drugs and medicines which are used to cure myelofibrosis. Myelofibrosis is a muscle disease and various types of myelofibrosis treatment are available in the market to cure this condition. The muscle disease is caused due to myelodysplasia, a genetically determined trait that prevents the muscle from growing properly. Myelofibrosis is also known as spider veins, lying in regions close to the skin, like the armpits, groin, elbows, and knees. Myelofibrosis is the most common type of connective tissue disease. These medicines are generally used to control and stop the progress of the disease, after which, they suppress the activity of the immune system. Various types of steroids are used as medicines for myelofibrosis, to control the activity of the immune system and thereby stop the disease in its tracks. One of the most common drugs for myelofibrosis treatment is prednisone, which is generally used along with steroids. However, to treat spider veins and not myelofibrosis, a compound called Finasteride is used. The most important part of myelofibrosis treatment is a regular check-up, as early as 18 months of the disease a doctor can monitor the progress of the disease. Myelofibrosis treatment also includes physical therapy and other treatments to improve the symptoms of myelofibrosis. The main driving factor influencing the growth of the myelofibrosis treatment market is the increasing prevalence of myelofibrosis in emerging economies. For instance, according to Gleneagles Global Hospitals, the yearly incidence rate of myelofibrosis in India is 0.3 to 1.5 cases per 100,000 individuals. Most of the times these cases goes unnoticed since it is sometimes asymptomatic or less severe. Moreover, the market is estimated to grow owing to a large number of R&D investments, a large cluster of patients suffering from myelofibrosis, and better reimbursement policies. Read more @ https://coherentmarketinsights-bl